ARTIELLE IMMUNOTHERAPEUTICS
Artielle ImmunoTherapeutics, Inc., a biopharmaceutical company, develops recombinant T-cell receptor ligands (RTLs) to treat T-cell mediated inflammatory diseases. It develops RTL1000, a compound for the treatment of multiple sclerosis. The company focuses on the development of therapeutics for the treatment of autoimmune diseases that include multiple sclerosis, celiac disease, type 1 diabetes, rheumatoid arthritis, uveitis, stroke, optic neuritis, and other diseases. Artielle ImmunoTherapeutics, Inc. was founded in 2004 and is based in Tigard, Oregon.
ARTIELLE IMMUNOTHERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2004-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.artielle.com
Total Employee:
1+
Status:
Active
Contact:
(650) 401-2000
Email Addresses:
[email protected]
Total Funding:
11.19 M USD
Technology used in webpage:
SPF LetsEncrypt Nginx Common Name Invalid PHP Parallels Plesk Panel Switch Hosted
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
SFA Therapeutics
SFA Therapeutics is a developer of drugs to treat chronic inflammatory diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
Northwest Technology Ventures
Northwest Technology Ventures investment in Series A - Artielle ImmunoTherapeutics
Tenex Greenhouse Ventures
Tenex Greenhouse Ventures investment in Series A - Artielle ImmunoTherapeutics
Sanderling Ventures
Sanderling Ventures investment in Series A - Artielle ImmunoTherapeutics
Pelion Venture Partners
Pelion Venture Partners investment in Series A - Artielle ImmunoTherapeutics
Official Site Inspections
http://www.artielle.com Semrush global rank: 13.13 M Semrush visits lastest month: 78
- Host name: cust-155.130.138.26.switch.com
- IP address: 155.130.138.26
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Artielle ImmunoTherapeutics"
Artielle ImmunoTherapeutics | Home
Artielle Immunotherapeutics is a clinical stage, venture-backed company developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases. …See details»
Artielle ImmunoTherapeutics - Crunchbase Company …
Organization. Artielle ImmunoTherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Artielle ImmunoTherapeutics | Company
Artielle Immunotherapeutics is a clinical stage, venture-backed company headquartered in Portland, OR. Artielle is developing a novel, first-in-class platform of biologic drugs to treat a …See details»
Artielle ImmunoTherapeutics - Overview, News & Similar
Who is Artielle ImmunoTherapeutics. Artielle Immunotherapeutics is a clinical stage, venture-backed company headquartered in Portland, OR. Artielle is developing a novel, first-in-cla ss …See details»
Artielle ImmunoTherapeutics - Funding, Financials, Valuation
Artielle ImmunoTherapeutics develops recombinant T-cell receptor ligands to treat T-cell-mediated inflammatory diseases. Search Crunchbase. Start Free Trial . ... How much funding …See details»
Artielle.com - AboutUs
Artielle ImmunoTherapeutics’ technology is focused on a new proprietary class of molecules known as Recombinant T cell receptor Ligands (RTLs) that can be tailored to treat a wide …See details»
Artielle ImmunoTherapeutics - Craft
Artielle ImmunoTherapeutics is a clinical-stage company developing a platform of biologic drugs to treat inflammatory and degenerative diseases. It focuses on diseases, such as multiple …See details»
Artielle ImmunoTherapeutics, Inc - VentureRadar
Artielle Immunotherapeutics is a clinical stage, venture-backed company developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases. …See details»
Artielle ImmunoTherapeutics - Org Chart, Teams, Culture & Jobs
Artielle Immunotherapeutics is a clinical stage, venture-backed company developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases. …See details»
Artielle ImmunoTherapeutics - PitchBook
Artielle ImmunoTherapeutics is headquartered in Tigard, OR. What is the size of Artielle ImmunoTherapeutics? Artielle ImmunoTherapeutics has 6 total employees. What industry is …See details»
Artielle ImmunoTherapeutics' Leadership Team - The Org
The leadership team at Artielle ImmunoTherapeutics has a long history of experience in the medical field. They have worked as professors at VA Medical Centers and OHSU, and as a …See details»
Artielle ImmunoTherapeutics - Contacts, Employees, Board …
Organization. Artielle ImmunoTherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. …See details»
Artielle ImmunoTherapeutics | Contact
Contact Address. Artielle Immunotherapeutics, Inc. c/o Reference Capital Management LLC 7320 SW Hunziker Rd., Suite 104 Tigard, OR 97223 Tel: 503-619-4310See details»
Artielle ImmunoTherapeutics, Inc - VentureRadar
Artielle Immunotherapeutics is a clinical stage, venture-backed company developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases. …See details»
Artielle ImmunoTherapeutics - Products, Competitors, Financials ...
Artielle ImmunoTherapeutics is a clinical stage, venture-backed company developing a platform of biologic drugs for inflammatory and degenerative diseases. Use the CB Insights Platform to …See details»
Artielle ImmunoTherapeutics, Inc. - discovery.patsnap.com
Artielle is a company that provides Pharmacy and Therapeutics, T-cell receptor, Medicine and more. Artielle is headquartered in United States California. Artielle was founded in 2004. …See details»
Artielle Immunotherapeutics - Reference Capital
Artielle Immunotherapeutics is a clinical stage, venture-backed company developing a novel, first-in-class platform of biologic drugs to treat a range of inflammatory and degenerative diseases. …See details»
Artielle ImmunoTherapeutics CEO and key executive team - Craft
Artielle ImmunoTherapeutics's key executives include Peter McWilliams and 1 others. Peter McWilliams. Director. John B. Metcalf. Interim CEO. Source: artielle.com. Report incorrect …See details»
Artielle Holdings LLC Overview - Salary.com
Artielle Holdings LLC Overview. Artielle Holdings LLC Information BETA. Headquarters Address: 1120 NW Couch St Fl 10, Portland, Oregon. Phone Number: Data pending, update soon. ...See details»
Artielle ImmunoTherapeutics | Pipeline
Autoimmune Inflammatory Diseases. The term "Autoimmune Disease" refers to a varied group of more than 80 serious, chronic illnesses that involve almost every human organ system.See details»